Aspartate is an endogenous metabolic limitation for tumour growth
Defining the metabolic limitations of tumour growth will help to develop cancer therapies 1 . Cancer cells proliferate slower in tumours than in standard culture conditions, indicating that a metabolic limitation may restrict cell proliferation in vivo. Aspartate synthesis can limit cancer cell prol...
Main Authors: | Sullivan, Lucas B. (Author), Luengo, Alba (Author), Danai, Laura V. (Author), Bush, Lauren N. (Author), Diehl, Frances F. (Author), Hosios, Aaron M. (Author), Lau, Allison N. (Author), Elmiligy, Sarah (Author), Lewis, Caroline A. (Author), Vander Heiden, Matthew G. (Author) |
---|---|
Other Authors: | Whitehead Institute for Biomedical Research (Contributor), Massachusetts Institute of Technology. Department of Biology (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor) |
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media LLC,
2020-04-30T13:00:27Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Cytosolic Aspartate Availability Determines Cell Survival When Glutamine Is Limiting
by: Alkan, H. Furkan, et al.
Published: (2020) -
Environment Dictates Dependence on Mitochondrial Complex I for NAD+ and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin
by: Freinkman, Elizaveta, et al.
Published: (2018) -
Acetate metabolism in cancer cells
by: Hosios, Aaron M, et al.
Published: (2014) -
Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapy
by: Luengo, Alba, et al.
Published: (2014) -
Reactive metabolite production is a targetable liability of glycolytic metabolism in lung cancer
by: Luengo, Alba, et al.
Published: (2020)